Villasanta-Gonzalez, Alejandro
Alcala-Diaz, Juan Francisco
Vals-Delgado, Cristina
Arenas, Antonio Pablo
Cardelo, Magdalena P.
Romero-Cabrera, Juan Luis
Rodriguez-Cantalejo, Fernando
Delgado-Lista, Javier
Malagon, Maria M.
Perez-Martinez, Pablo
Schulze, Matthias B.
Camargo, Antonio
Lopez-Miranda, Jose
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sex-specific differences in intestinal microbiota associated with cardiovascular diseases
https://doi.org/10.1186/s13293-024-00582-7
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
https://doi.org/10.1186/s12933-023-01933-1
Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
https://doi.org/10.1007/s00394-022-02854-7
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
https://doi.org/10.1007/s00394-022-03080-x
CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics
https://doi.org/10.1016/j.ahj.2016.04.011
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
https://doi.org/10.1186/s12933-021-01260-3
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
https://doi.org/10.1007/s00394-021-02676-z
Funding for this research was provided by:
Instituto de Salud Carlos III (PIE14/00005, PIE14/00031, CP14/00114, DTS19/00007, PI13/00023, PI16/01777)
Secretaría de Estado de Investigación, Desarrollo e Innovación (AGL2012/39615, AGL2015-67896-P, PCIN-2016-084)
joint programming initiative a healthy diet for a healthy life
Universidad de Córdoba
Article History
Received: 24 December 2020
Accepted: 24 June 2021
First Online: 5 October 2021
Declarations
:
: The author reports no conflicts of interest in this work.
: The trial protocol and amendments were approved by the local ethics committee of Reina Sofia University Hospital in Cordoba, following the Helsinki declaration and good clinical practices.
: All the patients gave written, informed consent to participate in the study.
: Not applicable.